Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

Authors
Publication date
1 January 2024
Publisher
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Institutional Research Information System University of Turin

      redirect
      oaioai:iris.unito.it:2318/1965115
      Last time updated on 01/11/2024